NCT06864884View on ClinicalTrials.gov

A Phase 1 Study of ARC-001 in Participants Undergoing Third Molar Extraction

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 26, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Acute Post Operative PainThird Molar Extraction Surgery
Interventions
DRUG

ARC-001

Gel formulation containing investigational anesthetic.

DRUG

Placebo gel

Gel that contains no active ingredients.

Trial Locations (1)

84107

RECRUITING

CenExel JBR, Salt Lake City

Sponsors
All Listed Sponsors
lead

Arcato Laboratories, Inc.

INDUSTRY

NCT06864884 - A Phase 1 Study of ARC-001 in Participants Undergoing Third Molar Extraction | Biotech Hunter | Biotech Hunter